MVAC chemotherapy-induced apoptosis and p53 alterations in the rat model of bladder cancer

Urology

Volumn 52, Issue 5, 1998, Pages 925-931

  Zhang, Xianghua ^a   Jin, Li ^a   Takenaka, Ikumasa ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CISPLATIN; DOXORUBICIN; METHOTREXATE; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PROTEIN P53; VINBLASTINE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER MODEL; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CISPLATIN; DOXORUBICIN; GENES, P53; MALE; METHOTREXATE; MUTATION; RATS; RATS, WISTAR; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0031740663     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00364-1     Document Type: Article

References (34)

1. Sternberg C.N., Yagoda A., Scher H.I., et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol. 139:1988;461-469.
2. Donat S.M., Herr H.W., Bajorin D.F., et al. Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer. J Urol. 156:1996;368-371.
3. Javadpour N., Daloni P. Histopathologic changes of transitional cell carcinoma of bladder after M-VAC chemotherapy. Urology. 34:1989;357-359.
4. Williams G.T. Programmed cell death apoptosis and oncogenesis . Cell. 65:1991;1097-1098.
5. Hickman J.A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11:1992;121-139.
6. King E., Matteson J., Jacobs S.C., et al. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder association with tumor progression . J Urol. 155:1996;316-320.
7. Chyle V., Pollack A., Czerniak B., et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 35:1996;281-287.
8. Baker S.J., Markowitz S., Fearon E.R., et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 249:1990;912-915.
9. Zhu Y.M., Bradbury D.A., Russell N.H. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer. 69:1994;468-472.
10. Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 329:1993;1318-1327.
11. International Union Against Cancer: TNM Classification of Malignant Tumors (4th ed.). New York: Springer-Verlag, 1987, pp 133-135.
12. Arends M.J., McGregor A.H., Wyllie A.H. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol. 144:1994;1045-1057.
13. Zhang X.H., Takenaka I. Basement membrane and tumor invasion ultrastructural observations in the basement membrane of rat bladder with invasive transitional cell carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine . Urol Res. 22:1994;317-322.
14. Zhang X.H., Takenaka I. Morphological changes in the basement membrane during progression from non-invasive to invasive rat bladder cancer induced by N-butyl-N-(4-hydroxbutyl)nitrosamine. Br J Urol. 79:1997;378-382.
15. Kerr J.F.R., Winterford C.M., Harmon B.V. Apoptosis Its significance in cancer and cancer therapy . Cancer. 73:1994;2013-2026.
16. Milas L., Stephens L.C., Meyn R.E. Relation of apoptosis to cancer therapy. In Vivo. 8:1994;665-673.
17. Simonian P.L., Grillot D.A., Nunez G. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood. 90:1997;1208-1216.
18. Lowe S.W., Bodis S., McClatchey A., et al. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
19. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death the significance of apoptosis . Int Rev Cytol. 68:1980;251-306.
20. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues an overview . Cancer Metastasis Rev. 11:1992;95-103.
21. Hockenberry D. Review defining apoptosis . Am J Pathol. 146:1995;16-19.
22. Franko A.J., Sutherland R.M. Oxygen diffusion distance and development of necrosis in multicell spheroids. Radiat Res. 79:1979;439-453.
23. Rotin D., Robinson B., Tannock I.F. Influence of hypoxia and an acid environment on the metabolism and viability of cultured cells potential implications for cell death in tumors . Cancer Res. 46:1986;2821-2826.
24. Eerola A.K., Tomanen U., Rainio P., et al. Apoptosis in operated small cell lung carcinoma is inversely related to tumor necrosis and p53 immunoreactivity. J Pathol. 181:1997;172-177.
25. Dole M., Nunez G., Merchant A.K., et al. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54:1994;3253-3259.
26. Borner M.M., Myers C.E., Sator O., et al. Drugs-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 55:1995;2122-2128.
27. Haupt Y., Rowan S., Shaulian E., et al. Induction of apoptosis in Hela cells by trans-activation-deficient p53. Genes Dev. 9:1995;2170-2183.
28. Han J., Sabbatini P., Perez D., et al. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:1996;461-477.
29. Saegusa M., Takano Y., Wakabayashi T., et al. Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. Jpn J Cancer Res. 86:1995;743-748.
30. Fujimoto K., Yamada A., Okajima E., et al. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res. 52:1992;1393-1398.
31. Vet J.A.M., Bringuier P.P., Poddighe P.J., et al. p53 mutations have no additional prognostic value over stage in bladder cancer. Br J Cancer. 70:1994;496-500.
32. Waldman T., Lengauer C., Kinzer K.W., et al. Upcoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 381:1996;713-716.
33. Cote R., Esrig D., Groshen S., et al. p53 and treatment of bladder cancer. Nature. 385:1997;123-124.
34. Lowe S.W., Ruley H.E., Jacks T., et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.